Norwegian Finans Holding ASA
We refer to previous announcements regarding the initiated merger process between Norwegian Finans Holding ASA and Bank Norwegian AS. Further, on 6 January 2021, it was announced that the Norwegian Financial Supervisory Authority had given its approval to change the group structure in order for Bank Norwegian AS to be the new parent company in the Group.
On 16 March 2021 the Board of Directors of Norwegian Finans Holding ASA and Bank Norwegian AS decided, in respective board meetings, to present for the Annual General Meetings the approval of a merger plan of the companies. The Annual General Meeting in Norwegian Finans Holding ASA and Bank Norwegian AS will be held at 27 April 2021.
The merger plan proposes that the companies' Annual General Meetings approve a merger of the two companies through a reversed parent subsidiary merger, involving the transfer of all assets, rights and obligations in Norwegian Finans Holding ASA to Bank Norwegian AS. Once the merger has been implemented, Norwegian Finans Holding ASA will be dissolved. The shareholders of Norwegian Finans Holding ASA will receive one share in Bank Norwegian AS for each share they own in Norwegian Finans Holding ASA. The merger plan will be published in accordance with the notice to the Annual General Meeting. The merger is scheduled to be completed during the first half of 2021, with accounting and tax effect from 1 January 2021.
The merger is considered to have no material effect nor adversely impact Norwegian Finans Holding ASA’ or Bank Norwegian AS’ ability to fulfill its obligations towards creditors under relevant agreements, including current senior preferred loan agreements, subordinated loan agreements and tier 1 capital instruments agreements.
For further information, please contact:
CFO Klara Lise Aasen; phone +47 47635583; kaa@banknorwegian.no
Head of Treasury Mats Benserud; phone +47 95891539; mbe@banknorwegian.no
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alveus Therapeutics Inc9.1.2026 09:13:19 CET | Pressemeddelelse
Alveus Therapeutics annoncerer serie A-financiering på 160 mio. USD til næste generations behandlinger mod fedme og stofskiftesygdomme
Yacht Club de Monaco9.1.2026 09:05:00 CET | Press release
At the Yacht Club de Monaco a year of transition and innovation begins
Onco3R Therapeutics BV9.1.2026 09:00:00 CET | Press release
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
Zealand Pharma9.1.2026 08:00:00 CET | Press release
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
Sparinvest SICAV9.1.2026 08:00:00 CET | Pressemeddelelse
Finanskalender for Sparinvest SICAV
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
